Swiss National Bank Boosts Stake in iRhythm Technologies, Inc. (NASDAQ:IRTC)

Swiss National Bank increased its position in iRhythm Technologies, Inc. (NASDAQ:IRTC) by 5.7% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 64,800 shares of the company’s stock after purchasing an additional 3,500 shares during the period. Swiss National Bank’s holdings in iRhythm Technologies were worth $15,371,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of IRTC. Point72 Hong Kong Ltd purchased a new stake in shares of iRhythm Technologies in the third quarter worth about $31,000. HM Payson & Co. purchased a new stake in iRhythm Technologies during the third quarter valued at approximately $33,000. Harvest Fund Management Co. Ltd raised its position in iRhythm Technologies by 50.5% during the third quarter. Harvest Fund Management Co. Ltd now owns 313 shares of the company’s stock valued at $70,000 after purchasing an additional 105 shares during the period. Aigen Investment Management LP purchased a new stake in iRhythm Technologies during the third quarter valued at approximately $203,000. Finally, Nisa Investment Advisors LLC raised its position in iRhythm Technologies by 245.3% during the third quarter. Nisa Investment Advisors LLC now owns 915 shares of the company’s stock valued at $218,000 after purchasing an additional 650 shares during the period.

Shares of NASDAQ:IRTC opened at $159.03 on Tuesday. iRhythm Technologies, Inc. has a 52-week low of $56.54 and a 52-week high of $286.19. The stock has a market cap of $4.59 billion, a P/E ratio of -83.26 and a beta of 1.68. The business’s 50 day moving average is $208.77 and its 200 day moving average is $218.65. The company has a quick ratio of 6.46, a current ratio of 6.55 and a debt-to-equity ratio of 0.07.

IRTC has been the topic of a number of recent research reports. Morgan Stanley upped their price objective on iRhythm Technologies from $227.00 to $288.00 and gave the company an “overweight” rating in a research report on Monday, January 25th. William Blair restated a “buy” rating on shares of iRhythm Technologies in a research report on Thursday, December 10th. Smith Barney Citigroup decreased their price objective on iRhythm Technologies from $275.00 to $238.00 in a research report on Thursday, December 3rd. TheStreet upgraded iRhythm Technologies from a “d” rating to a “c-” rating in a research report on Friday, November 6th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of iRhythm Technologies in a report on Friday, January 29th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have given a buy rating to the stock. iRhythm Technologies has a consensus rating of “Buy” and an average target price of $218.77.

In related news, EVP David A. Vort sold 10,000 shares of the stock in a transaction that occurred on Tuesday, December 15th. The stock was sold at an average price of $210.00, for a total value of $2,100,000.00. Following the transaction, the executive vice president now owns 23,379 shares of the company’s stock, valued at $4,909,590. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP David A. Vort sold 5,000 shares of the stock in a transaction that occurred on Tuesday, December 22nd. The stock was sold at an average price of $231.91, for a total value of $1,159,550.00. Following the completion of the transaction, the executive vice president now directly owns 20,602 shares in the company, valued at approximately $4,777,809.82. The disclosure for this sale can be found here. In the last three months, insiders sold 45,000 shares of company stock worth $10,453,750. 3.10% of the stock is owned by insiders.

iRhythm Technologies Company Profile

iRhythm Technologies, Inc, a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias.

Read More: What are Institutional Investors?

Want to see what other hedge funds are holding IRTC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iRhythm Technologies, Inc. (NASDAQ:IRTC).

Institutional Ownership by Quarter for iRhythm Technologies (NASDAQ:IRTC)

Receive News & Ratings for iRhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.